Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Identification of gene expression signature in estrogen receptor positive breast carcinoma.

Thakkar AD, Raj H, Chakrabarti D, Ravishankar, Saravanan N, Muthuvelan B, Balakrishnan A, Padigaru M.

Biomark Cancer. 2010 Feb 11;2:1-15. doi: 10.4137/BIC.S3793. eCollection 2010.

2.

Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability.

Skrzypczak M, Goryca K, Rubel T, Paziewska A, Mikula M, Jarosz D, Pachlewski J, Oledzki J, Ostrowski J.

PLoS One. 2010 Oct 1;5(10). pii: e13091. doi: 10.1371/journal.pone.0013091. Erratum in: PLoS One. 2010;5(12) doi: 10.1371/annotation/8c585739-a354-4fc9-a7d0-d5ae26fa06ca. Ostrowsk, Jerzy [corrected to Ostrowski, Jerzy].

3.

Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer.

Sanchez-Palencia A, Gomez-Morales M, Gomez-Capilla JA, Pedraza V, Boyero L, Rosell R, Fárez-Vidal ME.

Int J Cancer. 2011 Jul 15;129(2):355-64. doi: 10.1002/ijc.25704. Epub 2010 Nov 28.

4.

Knockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesion.

Yin X, Rana K, Ponmudi V, King MR.

Carbohydr Res. 2010 Nov 2;345(16):2334-42. doi: 10.1016/j.carres.2010.07.028. Epub 2010 Jul 21.

5.

Prognostic value of mucin 4 expression in colorectal adenocarcinomas.

Shanmugam C, Jhala NC, Katkoori VR, Wan W, Meleth S, Grizzle WE, Manne U.

Cancer. 2010 Aug 1;116(15):3577-86. doi: 10.1002/cncr.25095.

6.

A common gain of function of p53 cancer mutants in inducing genetic instability.

Liu DP, Song H, Xu Y.

Oncogene. 2010 Feb 18;29(7):949-56. doi: 10.1038/onc.2009.376. Epub 2009 Nov 2.

7.

Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin.

Zaanan A, Cuilliere-Dartigues P, Guilloux A, Parc Y, Louvet C, de Gramont A, Tiret E, Dumont S, Gayet B, Validire P, Fléjou JF, Duval A, Praz F.

Ann Oncol. 2010 Apr;21(4):772-80. doi: 10.1093/annonc/mdp383. Epub 2009 Oct 15.

PMID:
19833818
8.

Copy number and gene expression alterations in radiation-induced papillary thyroid carcinoma from chernobyl pediatric patients.

Stein L, Rothschild J, Luce J, Cowell JK, Thomas G, Bogdanova TI, Tronko MD, Hawthorn L.

Thyroid. 2010 May;20(5):475-87. doi: 10.1089/thy.2009.0008.

PMID:
19725780
9.

IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis.

White CD, Brown MD, Sacks DB.

FEBS Lett. 2009 Jun 18;583(12):1817-24. doi: 10.1016/j.febslet.2009.05.007. Epub 2009 May 9. Review.

10.

Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma.

Katkoori VR, Jia X, Shanmugam C, Wan W, Meleth S, Bumpers H, Grizzle WE, Manne U.

Clin Cancer Res. 2009 Apr 1;15(7):2406-16. doi: 10.1158/1078-0432.CCR-08-1719.

11.

IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascade.

Nojima H, Adachi M, Matsui T, Okawa K, Tsukita S, Tsukita S.

Nat Cell Biol. 2008 Aug;10(8):971-8. doi: 10.1038/ncb1757. Epub 2008 Jul 6.

PMID:
18604197
12.

Functional classification analysis of somatically mutated genes in human breast and colorectal cancers.

Chittenden TW, Howe EA, Culhane AC, Sultana R, Taylor JM, Holmes C, Quackenbush J.

Genomics. 2008 Jun;91(6):508-11. doi: 10.1016/j.ygeno.2008.03.002. Epub 2008 Apr 22.

13.

Clinical significance of a novel single nucleotide polymorphism in the 5' untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma.

Katkoori VR, Jia X, Chatla C, Kumar S, Ponnazhagan S, Callens T, Messiaen L, Grizzle WE, Manne U.

Front Biosci. 2008 Jan 1;13:1050-61.

14.

Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia.

Lee S, Jeong J, Majewski T, Scherer SE, Kim MS, Tuziak T, Tang KS, Baggerly K, Grossman HB, Zhou JH, Shen L, Bondaruk J, Ahmed SS, Samanta S, Spiess P, Wu X, Filipek S, McConkey D, Bar-Eli M, Issa JP, Benedict WF, Czerniak B.

Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13732-7. Epub 2007 Aug 16.

15.

Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma.

Roberts RA, Sabalos CM, LeBlanc ML, Martel RR, Frutiger YM, Unger JM, Botros IW, Rounseville MP, Seligmann BE, Miller TP, Grogan TM, Rimsza LM.

Lab Invest. 2007 Oct;87(10):979-97. Epub 2007 Aug 13.

16.

Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer.

Kosaka Y, Inoue H, Ohmachi T, Yokoe T, Matsumoto T, Mimori K, Tanaka F, Watanabe M, Mori M.

Ann Surg Oncol. 2007 Sep;14(9):2543-9. Epub 2007 Jun 28.

PMID:
17597343
17.
18.

Performance of different small sample RNA amplification techniques for hybridization on Affymetrix GeneChips.

Wagner F, Radelof U.

J Biotechnol. 2007 May 10;129(4):628-34. Epub 2007 Feb 25.

PMID:
17408796
19.

Structure-function-rescue: the diverse nature of common p53 cancer mutants.

Joerger AC, Fersht AR.

Oncogene. 2007 Apr 2;26(15):2226-42. Review.

PMID:
17401432
20.

Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection.

Molleví DG, Serrano T, Ginestà MM, Valls J, Torras J, Navarro M, Ramos E, Germà JR, Jaurrieta E, Moreno V, Figueras J, Capellà G, Villanueva A.

Carcinogenesis. 2007 Jun;28(6):1241-6. Epub 2007 Jan 27.

PMID:
17259658

Supplemental Content

Support Center